Hepple, Jonathan Paul, Dr
At least 6 active companies
These details are public data from the Companies House register.
- Nationality
- British
- Country of residence
- United Kingdom
Appointments 6 current
Not a complete list. See all appointments on Companies House
Director · Appointed 30 November 2020
Active
Net assets £4.7M, 2020 accounts (newer filed) · Incorporated 2019
Director · Appointed 2 May 2013
Active
Total exemption full accounts · Incorporated 2006
Director · Appointed 8 November 2024
Active
Total exemption full accounts · Incorporated 2024
Director · Appointed 24 March 2021
Active
Full accounts · Incorporated 2011
Director · Appointed 6 August 2013
Active
Total exemption full accounts · Incorporated 2013
Director · Appointed 2 May 2013
Active
Total exemption full accounts · Incorporated 2012
Works with
Officers serving alongside Hepple, Jonathan Paul, Dr
Anninga, Bauke, Dr
Director at Nucleome Therapeutics Limited
Corporate Secretary at Rosetta Capital V GP Limited
Bodmer, Mark
Director at Nucleome Therapeutics Limited
Davis, John
Director at Nucleome Therapeutics Limited
Forer, Michael
Director at Rosetta Partners Limited
Forer, Michael
Director at Rosetta Capital IV GP Limited
Director at BML General Partner Limited